Cure My Disease

Don't miss your cure!

 Log in / Sign up

New acne gel shows promise in large trial

NCT ID NCT07384195

Ongoing Symptom relief Sponsor: PPM Services S.A. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 3 trial tests a new gel called N-Acetyl-GED-0507-34-LEVO for acne vulgaris. About 400 people will apply the gel or a placebo daily for 12 weeks. Researchers will count pimples and rate skin clarity to see if the gel works better than placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
N-Acetyl-GED-0507-34-LEVO gel 5%
What this could lead to
If it works, this could provide a new topical treatment option for acne vulgaris, helping to reduce pimples and improve skin appearance.
What could go wrong
This is a Phase 3 trial, but results may show the gel is no better than placebo. Side effects like skin irritation are possible. Success in this trial does not guarantee approval or widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE VULGARIS

Contacts and locations

Locations

  • Azienda Ospedaliera Policlinico Universitario Tor Vergata

    Roma, RM, 00133, Italy

  • Azienda Ospedaliera Universitaria Federico II Di Napoli

    Naples, 80131, Italy

  • Azienda Ospedaliero Universitaria Delle Marche

    Ancona, AN, 60126, Italy

  • Azienda Ospedaliero Universitaria Parma

    Parma, PR, 43126, Italy

  • Azienda USL Toscana Centro

    Florence, FI, 50125, Italy

  • Centrum Zdrowia Dziecka I Rodziny Im. Jana Pawla II W Sosnowcu Sp. z o.o.

    Sosnowiec, Poland

  • DERMAPOLIS Medical Dermatology Center dr n.med. Edyta Gebska

    Chorzów, Poland

  • Dermed Centrum Medyczne Sp. z o.o.

    Lodz, Poland

  • EMC Instytut Medyczny S.A.

    Wroclaw, Poland

  • Fondazione IRCCS Policlinico San Matteo

    Pavia, PV, 27100, Italy

  • Futuremeds Spain S.L.

    Madrid, 28003, Spain

  • Futuremeds Spain S.L.

    Seville, 41012, Spain

  • Hospital Quironsalud Infanta Luisa

    Seville, 41010, Spain

  • Hospital Universitario Hm Sanchinarro

    Madrid, Spain

  • Hospital Universitario Regional De Malaga

    Málaga, 29010, Spain

  • Hospital Universitario Virgen De La Victoria

    Málaga, 29010, Spain

  • I.F.O. Istituti Fisioterapici Ospitalieri

    Roma, RM, 00144, Italy

  • IRCCS Ospedale Policlinico San Martino

    Genova, GE, 16132, Italy

  • Klinika Ambroziak Sp. z o.o.

    Warsaw, Poland

  • Labderm Essence Sp. z o.o.

    Ożarowice, Poland

  • Lukmed 2 Sp. z o.o.

    Siedlce, Poland

  • Provita Sp. z o.o.

    Katowice, Poland

  • Royalderm Agnieszka Nawrocka

    Warsaw, Poland

  • Sant Joan De Deu Barcelona Hospital

    Esplugues de Llobregat, 08950, Spain

  • Silmedic Sp. z o.o.

    Katowice, Poland

  • St-Inspire Sp. z o.o.

    Mikołów, Poland

  • Twoja Przychodnia Nowosolskie Centrum Medyczne Sp. z o.o.

    Nowa Sól, Poland

  • Twoja Przychodnia Poznanskie Centrum Medyczne Sp. z o.o.

    Poznan, Poland

  • Vitamed Galaj I Cichomski Sp. j.

    Bydgoszcz, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.